Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update

By Proactive Investors / June 13, 2023 / www.youtube.com / Article Link


Context Therapeutics CEO Marty Lehr joins Natalie Stoberman from the Proactive studios to discuss the latest data on clinical ...

Recent News

Agnico Eagle's production dip and higher costs offset by jump in gold
February 17, 2026 / www.canadianminingreport.com

Barrick, Agnico Eagle report extremely strong Q4/25 results
February 17, 2026 / www.canadianminingreport.com

Metals far outpacing tech over past year
February 09, 2026 / www.canadianminingreport.com

Gold stocks gain on metal recovery
February 09, 2026 / www.canadianminingreport.com

Immediate trigger for crash was new Fed Chairman pick
February 02, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok